|
Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.
| ||
NOT A SUBSCRIBER?Roche makes hostile bid for GenentechPosted on January 30, 2009 12:13 PM
Having failed to win over the Genentech Inc. board last summer, Roche Holding AG on Friday unveiled a cut-rate $42.5 billion hostile offer for the minority of Genentech that it doesn't already own.
Roche, with headquarters in Basel, Switzerland, said it would pay $86.50 per Genentech share to mop up the 44% not already under its control. That's 3% less than the $89 it offered about six months ago and also a nearly 3% discount to Genentech's Thursday close. This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools. To request a demo, or, if you are an existing user to The Deal Pipeline, login to your account, please scroll down and click the button. Dig deeper, with Pipeline.
Most searched keywords
|
|
EXISTING USERS Missing a product? |
Michael Crosby mcrosby@thedeal.com 212.313.9325 |
Martha Brown mbrown@thedeal.com 212.313.9218 |